Skip to content

Three Good Things (3GT) - Intervention for Transitional Care Patients

Three Good Things (3GT) - Intervention for Transitional Care Patients at the Mayo Clinic Bloomer Critical Access Hospital

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04970641
Enrollment
25
Registered
2021-07-21
Start date
2021-09-30
Completion date
2023-12-01
Last updated
2024-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Positive Thinking, Psychology, Positive, Resilience, Psychological

Brief summary

Researchers are doing this research study to learn how the Three Good Things (3GT) Positive Psychology journaling activity affects symptoms of stress, depression, resilience, and happiness.

Detailed description

The purpose of this study is to measure, rank and categorize the subject sample of depression, stress, resilience and happiness scores using quantitative surveys. This research aims to learn how a Three Good Things (3GT) journaling activity affects a subject's symptoms of stress, depression, resilience and happiness. The data will allow the project team to gain an in-depth understanding of the impact of the use of resilience strategies from a hospitalized patient's perspective. The project aims to review if there is a correlation between stress, depression, resiliency, and happiness scores to the use of Positive Psychology.

Interventions

BEHAVIORALThree Good Things (3GT) Positive Psychology journaling activity

Evening journaling activity each day to reflect on three good things that the subject has noticed about their day's events.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Individuals ≥ 18 years of age. * Current inpatient at the Mayo Clinic Health System Bloomer Hospital, Bloomer, Wisconsin (a Swing Bed Hospital as defined by the Center for Medicare and Medicaid Services (CMS)). * Able to speak English. * Able to answer questionnaires.

Exclusion criteria

* Individuals \< 18 years of age. * Patient unwilling or unable to provide consent to participate in this research study. * Patient under guardianship. * As determined through self-report, patient in active psychosis, active suicidal ideation, active substance abuse meeting criteria for substance use disorders except for nicotine (the exception is patients with a history of substance abuse that have been in remission for at least one full year). * Patient diagnosed with obsessive-compulsive disorder, active panic disorder with agoraphobia or other phobic disorder, active Post Traumatic Stress Disorder, or active severe personality disorders. * Patient with previous participation in this study.

Design outcomes

Primary

MeasureTime frameDescription
Perceived StressBaseline, 6 weeksChange in subject perceived stress measured using the self-reported perceived stress scale (PSS). A 10-item questionnaire assessing individuals' appraisal of stress using a scale of 0=never, 4=very often.

Secondary

MeasureTime frameDescription
Subjective DepressionBaseline, 6 weeksChange in subject depression measured using the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R-10).
Subjective HappinessBaseline, 6 weeksChange in subject happiness measured using the self-reported subjective happiness scale (SHS). A 4-item scale of global subjective happiness. Two items ask respondents to characterize themselves using both absolute ratings and ratings relative to peers, whereas the other two items offer brief descriptions of happy and unhappy individuals and ask respondents the extent to which each characterization describes them.
Subjective ResilienceBaseline, 6 weeksChange in subject resiliency scores measured by the Connor-Davidson Resilience Scale (CD-RISC 2)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026